GlassScriptPhysician profile
Robin S Adamson
NPI 1649220401
$1,414.85
in general payments reported to CMS, 2019-2025
14 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $219 · 2023: $221 · 2024: $408 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $912.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $329.67 | 2022-2025 | Proclaim, Infinity |
| Boston Scientific Corporation | $244.26 | 2021-2024 | Intracept, Therasphere Y90 Glass Microspheres 10 Gbq |
| Abbvie INC. | $178.17 | 2021-2024 | Botox |
| Nevro Corp. | $137.33 | 2024 | Senza |
| Spr Therapeutics, INC | $130.00 | 2025 | Sprint Pns System |
| Biohaven Pharmaceuticals, INC. | $123.86 | 2021 | |
| Novartis Pharmaceuticals Corporation | $88.36 | 2021 | |
| Acorda Therapeutics, INC | $36.87 | 2022 | |
| Sunovion Pharmaceuticals INC. | $35.21 | 2022 | |
| Nalu Medical, INC. | $29.55 | 2025 | Nalu Neurostimulation System |
| Tempus Ai, INC | $28.41 | 2024 | Tempus Pixel |
| Biohaven Pharmaceutical Holding Company LTD. | $20.99 | 2022 | |
| Biogen, INC. | $17.04 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Adamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.